Dr. Adina Luba Kalet Selected as NBME’s 2023 John P. Hubbard Award Recipient
03 avr. 2023 09h15 HE
|
NBME
PHILADELPHIA, April 03, 2023 (GLOBE NEWSWIRE) -- Adina Luba Kalet, MD, MPH, FACP, FAACH, was selected as the recipient of NBME’s 2023 John P. Hubbard Award in recognition of her extensive...
GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey”
20 mars 2023 08h45 HE
|
GeneDx Holdings Corp.
Genome Sequencing and Interpretation Services Progressing Quickly for 1,000 Newborns Enrolled in Study to Date; On Track to Support up to 100,000 Study Participants in Next Four YearsInitial Data and...
Global Flow Cytometry Market Analysis Report 2022-2030 Featuring BD and Co, Beckman Coulter, Thermo Fisher Scientific, Bio-Rad Laboratories, Sony, & Miltenyi Biotec
01 mars 2023 10h18 HE
|
Research and Markets
Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Global Flow Cytometry Market Size and Share Analysis By Technology, Offering, Application, End-user - Forecast to 2030" report has been added to ...
Accelerating Innovation for the Spinal Cord Injury Community
23 févr. 2023 19h20 HE
|
Praxis Spinal Cord Institute
Vancouver, BC, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Praxis Spinal Cord Institute NEWS RELEASE For Immediate Release February 23, 2023 VANCOUVER, BC – February 23, 2023 – Praxis Spinal...
Barrow Women’s Board reaches milestone of $100M raised through Barrow Grand Ball
27 janv. 2023 17h07 HE
|
Barrow Neurological Institute at Dignity Health St. Joseph's Hospital and Medical Center
PHOENIX, Jan. 27, 2023 (GLOBE NEWSWIRE) -- PHOENIX, Ariz. (January 26, 2023) – The Women’s Board of Barrow Neurological Foundation netted over $7 million for Barrow Neurological Institute through...
Odyssey Health, Inc. To Develop Intranasal Field- Deliverable Nerve Agent Antidote
12 janv. 2023 08h30 HE
|
Odyssey Health, Inc
Las Vegas Nevada, Jan. 12, 2023 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...
Alphalyse and Bavarian Nordic A/S significantly shorten the time necessary to document HCP impurities in COVID-19 vaccine candidate for Phase 3 clinical trial – through world’s first MS-based HCP analysis under GMP conditions
03 janv. 2023 07h53 HE
|
Alphalyse A/S
ODENSE, Denmark, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Alphalyse has performed the world’s first GMP-certified mass spectrometry (MS)-based Host Cell Protein (HCP) analysis for product release testing...
Odyssey Health, Inc. Provides a Year End Update on Company and Corporate Outlook for 2023
19 déc. 2022 08h30 HE
|
Odyssey Health, Inc
Las Vegas, Nevada, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing life-enhancing medical products, today...
Global Bacteriophage Therapy Market Report 2022: Minimal Drug Toxicity, Self-Replication and Less Side Effects Among Benefits Fueling Adoption
28 nov. 2022 08h43 HE
|
Research and Markets
Dublin, Nov. 28, 2022 (GLOBE NEWSWIRE) -- The "Bacteriophage Therapy Market: Distribution by Therapeutic Area, Route of Administration, and Geography: Industry Trends and Global Forecasts,...
Odyssey Health, Inc. Provides Update on Company and the Progress of Concussion Drug Development
23 nov. 2022 08h30 HE
|
Odyssey Health, Inc
Las Vegas, Nevada, Nov. 23, 2022 (GLOBE NEWSWIRE) -- Odyssey Health, Inc. (OTC: ODYY), f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical...